Clinical development of fibrinolytic medicinal products in the treatment of patients with ST -segment elevation acute myocardial infarction (STEMI)

Current effective version

This document has been superseded by Guideline on clinical investigation of new medicinal products for the treatment of acute coronary syndrome (EMA/CHMP/760125/2016)

Reference numberCPMP/EWP/6235/04
Effective from01/12/2003
KeywordsST segment elevation, acute coronary syndrome, myocardial infarction, angina, revascularisation, anticoagulants, antithrombotics, stent thrombosis
DescriptionThis document provides guidance on the clinical development of new fibrinolytics in the treatment of patients with ST segment elevation acute myocardial infarction.

Document history

Revision 1

Draft guideline

PDF iconConcept paper

Published: 15/10/2014

Published: 15/10/2014

First version PDF iconAdopted guideline In operation: 01/12/2003 - 01/03/2018

Related content

How useful was this page?

Add your rating